Alira Health

Vaccines

Vaccine Recommendation Strategy

Illustrate the value of your product and ensure its inclusion of your product in the national recommendations

Tailored strategy from in-house experts

Securing recommendation for your vaccine requires an understanding of the market and health system dynamics. Work closely with our in-house experts to create a tailored strategy designed to navigate market access efficiently and gaining the recommendations to make your product available to patients.

The right strategy drives timing, access, and profitability, and helps you to protect the patients’ lives more effectively.

Why choose Alira Health?

When it comes to strategic planning, you’ll benefit from our:

  • Ability to gain full understanding of your products’ value and to effectively incorporate it into the recommendation strategy
  • Focused attention on your specific needs and individual aspects of your vaccine
  • In-house industry experts with over 25 years of experience working with the key market stakeholders—from payers to doctors
  • In-depth knowledge of industry challenges—and how to meet them

Working together to transform healthcare

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

Contact us
Bernd Schollmeier
Bernd Shollmier
Vice President of Global Market Access Vaccines
We are seeing a lot of traction in the industry, as well as interest in vaccine production. To support companies in a challenging payer environment, we created a dedicated vaccine division in our Global Market Access department to provide a variety of solutions that maximize patient access and the gross-to-net value of the product across the full product lifecycle.

Related News

News September 1, 2026
Alira Health Advises Mindful Capital Partners on the Sale of Portfolio Company Sidam S.r.l. to Plastiflex Group
Alira Health is pleased to have acted as Vendor Due Diligence Advisor to Mindful Capital Partners, an independent cross-border private equity firm focused on mid-market companies across(...)
MedTech
Reports and White Papers September 1, 2026
Global Medtech Contract Development and Manufacturing Market H1 2026 M&A Update
Learn about the H1 2026 M&A trends in the medtech CDMO market including deal activity, geographic distribution of transactions, and target end-markets.
CDMO MedTech
Articles August 19, 2026
How to Develop Global Clinical Evidence Strategies for Regulatory Success in Medtech
Discover how a strategically planned clinical evidence generation strategy can support global device approval, maximize evidence value, and prepare for international expansion.
MedTech Regulatory
Events July 24, 2026
MedTech World Asia 2026
Meet our team at MedTech World Asia 2026 and learn how our integrated model can support your international expansion and drive commercial success.
MedTech
Articles July 24, 2026
How Pharma and Medtech Convergence Is Changing DDS Partner Selection in 2026
Learn how pharma and medtech convergence is reshaping drug delivery system partner selection, from combination products and regulatory readiness to integrated execution.
Drug Delivery MedTech Pharma
Articles May 12, 2026
Frequently Asked Questions on the Strategic Value of Dual Branding in Pharma
Discover how dual branding in pharma enables pricing flexibility and expands access, and how to design a strategy that protects value and withstands scrutiny.
Interview Market Access Pharma
Articles April 24, 2026
From Approval to Adoption: A New Framework for Medtech Success
Medtech success requires more than approval. Discover how aligning evidence, patient needs, and market access drives adoption.
Interview MedTech Regulatory
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.